Artificial Intelligence: The New "Fuel" to Accelerate Pharmaceutical Development.

Journal: Current pharmaceutical design

Published Date: Jan 1, 2022

No abstract available for this article.

Panteleimon Pantelidis

3rd Department of Cardiology, Sotiria Thoracic Diseases General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Michael Spartalis

3rd Department of Cardiology, Sotiria Thoracic Diseases General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
George Zakynthinos

3rd Department of Cardiology, Sotiria Thoracic Diseases General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Artemis Anastasiou

3rd Department of Cardiology, Sotiria Thoracic Diseases General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Athina Goliopoulou

3rd Department of Cardiology, Sotiria Thoracic Diseases General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Evangelos Oikonomou

Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Dimitrios C Iliopoulos

Laboratory of Experimental Surgery and Surgical Research 'N.S. Christeas', Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Gerasimos Siasos

First Department of Cardiology, Hippokration Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Artificial Intelligence Big Data Drug Development Humans

View on PubMed Access via DOI PubMed (35909280)